Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis
Abstract Dihydropyridine calcium channel blockers (DHPCCBs) are widely used to treat hypertension and chronic coronary artery disease. One common adverse effect of DHPCCBs is peripheral edema, particularly of the lower limbs. The side effect could lead to dose reduction or discontinuation of the med...
Main Authors: | Ling Liang, Janice Y. Kung, Bradley Mitchelmore, Andrew Cave, Hoan Linh Banh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14436 |
Similar Items
-
COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01) -
Angiotensin‐converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta‐analysis
by: Yiyun Hu, et al.
Published: (2023-08-01) -
THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015-09-01) -
TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN
by: I. N. DYAKOV
Published: (2016-12-01) -
FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)